 |
|
|
Advisory Committee on Immunization Practices |
|
| FROM THE CENTERS FOR DISEASE CONTROL AND PREVENTION |
|
ACIP Recommendations: Human papillomavirus (HPV) |
|
|
| |
|
|
Recommendations - Human papillomavirus (HPV) |
|
|
|
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
Source: MMWR, December 23, 2011; 60(50):1705-8 |
|
| HTML | PDF |
| |
Sexually Transmitted Diseases
Treatment Guidelines, 2010
(Not an ACIP statement but an
important document. Includes information on hepatitis A, hepatitis
B, and human papillomavirus [HPV] vaccination.)
Source: MMWR, December 17, 2010; 59(RR12):1-110 |
|
|
HTML | PDF |
| |
FDA Licensure of Bivalent
Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and
Updated HPV Vaccination Recommendations from the Advisory Committee on
Immunization Practices (ACIP)
Source: MMWR, May 28, 2010;
59(20):626-629 |
|
| HTML | PDF |
| |
FDA Licensure of
Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in
Males and Guidance from the Advisory Committee on Immunization
Practices (ACIP) Weekly
Source: MMWR, May 28, 2010;
59(20):630-632 |
|
| HTML | PDF |
| |
Quadrivalent
Human Papillomavirus Vaccine
Source: MMWR, March 23, 2007; 56(RR02):1-24 |
|
| HTML | PDF |
| |
| This page was reviewed
on December 26, 2010 |
|
|
|
|
|
|
|
Immunization Action Coalition • 1573 Selby Ave • St. Paul, MN 55104 |
|
tel 651-647-9009 • fax 651-647-9131 |
|
|
| |
|
|
|
This website is supported in part by a cooperative agreement from the National Center for Immunization and Respiratory Diseases (Grant No. 5U38IP000290) at the Centers for Disease Control and Prevention (CDC) in Atlanta, GA. The website content is the sole responsibility of IAC and does not necessarily represent the official views of CDC. |
|
|
| |
| |
|
|
|
A-Z
IAC Home